Articles

RHOA regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China; Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Georgia Cancer Center, Augusta University, Augusta, GA 30912, USA; Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Georgia Cancer Center, Augusta University, Augusta, GA 30912
Haematologica Early view Jul 14, 2022 https://doi.org/10.3324/haematol.2022.280757